Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt
Calgary, Alberta--(Newsfile Corp. - September 24, 2026) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, announces that it proposes to settle debts in the aggregate amount of $192,300 (the "Debt") through the issuance of common shares of the Company ("Common Shares") at a deemed price of $0.155 per Common Share, being the closing price of the Common Shares...
More from Commercial newswire
- Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) and its Board for Possible Securities Law Violations
- Torex Gold Provides Q3 2026 Morelos Drilling & Exploration Update
- Universal Digital Inc. Announces Second Amendment to Helena Promissory Note
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →